Disparate regulation of signaling proteins after exercise and myocardial infarction

Medicine and Science in Sports and Exercise

Volumn 38, Issue 3, 2006, Pages 455-462

  Gosselin, Hugues ^a   Béliveau, Louise ^b   Burelle, Yan ^b   Clément, Robert ^a   Lajoie, Claude ^c   El Helou, Viviane ^a,b   Calderone, Angelino ^a,b  

^a MONTREAL HEART INSTITUTE   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAURENTIAN UNIVERSITY   (Canada)

Author keywords

Coronary artery disease; Heart failure; Physiological hypertrophy; Rats; Signal transduction introduction

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; S6 KINASE; SERINE; THREONINE;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CORONARY ARTERY DISEASE; DISEASE COURSE; ENZYME ACTIVATION; EXERCISE; FEMALE; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SCAR FORMATION; SIGNAL TRANSDUCTION;

ANIMALS; CORONARY ARTERIOSCLEROSIS; FEMALE; MYOCARDIAL INFARCTION; PHYSICAL CONDITIONING, ANIMAL; PROTO-ONCOGENE PROTEINS C-AKT; QUEBEC; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

EID: 33644836419     PISSN: 01959131     EISSN: None     Source Type: Journal    
DOI: 10.1249/01.mss.0000205138.02440.79     Document Type: Article

References (34)

1. ALESSI, D. R., S. R. JAMES, C. P. DOWNES, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha. Curr. Biol. 1: 261-266, 1997.
2. ANVERSA, P., R. RICCI, and G. OLIVETTI. Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy. J. Am. Coll. Cardiol. 7:1140-1146, 1986.
3. BOLUYT, M. O., J. S. ZHENG, A. YOUNES, et al. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70S6 kinase. Circ. Res. 81:176-186, 1997.
4. BUENO, O. F., L. J. DE WINDT, H. W. LIM, et al. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ. Res. 88:88-96, 2001.
5. BUENO, O. F., L. J. DE WINDT, K. M. TYMITZ, et al. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J. 19:6341-6350, 2000.
6. CALDERONE, A., R. J. L. MURPHY, J. LAVOIE, F. COLOMBO, and L. BELIVEAU. TGF-α1 and prepro-ANP mRNAs are differentially regulated in exercise-induced cardiac hypertrophy. J. Appl. Physiol. 91:771-776, 2001.
7. CHOU, M. M., and J. BLENIS. The 70 kD S6 kinase: regulation of a kinase with multiple roles in mitogenic signaling. Curr. Opin. Cell. Biol. 7:806-814, 1995.
8. COLOMBO, F., H. GOSSELIN, V. EL-HELOU, and A. CALDERONE. β-adrenergic receptor-mediated DNA synthesis in cardiac fibroblasts proceeds via a phosphatidylinositol 3-kinase dependent pathway refractory to the antiproliferative action of cyclic AMP. J. Cell. Physiol. 195:322-330, 2003.
9. CONDORELLI, G., A. DRUSCO, G. STASSI, et al. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Natl. Acad. Sci. USA 99:12333-12338, 2002.
10. DORN, G. W., and T. FORCE. Protein kinase cascades in the regulation of cardiac hypertrophy. J. Clin. Invest. 115:527-537, 2005.
11. GEENEN, D. L., A. MALHOTRA, and P. M. BUTTRICK. Angiotensin receptor 1 blockade does not prevent physiological cardiac hypertrophy in the adult rat. J. Appl. Physiol. 81:816-821, 1996.
12. GERDES, A. M., S. E. KELLERMAN, J. A. MOORE, et al. Structural remodelling of cardiac myocytes in patients with ischemic cardiomyopathy. Circulation 86:426-430, 1992.
13. GROSSMAN, W., D. JONES, and L. P. MCLAURIN. Wall stress and patterns of cardiac hypertrophy in the human left ventricle. J. Clin. Invest. 56:56-64, 1974.
14. KRAMER, C. M., W. J. ROGERS, C. S. PARK, et al. Regional myocyte hypertrophy parallels regional myocardial dysfunction during post-infarct remodelling. J. Mol. Cell. Cardiol. 30: 1773-1778, 1998.
15. LAJOIE, C., F. TRUDEAU, N. LAVOIE, et al. Exercise training attenuated the PKB and GSK-3 dephosphorylation in the myocardium of ZDF rats. J. Appl. Physiol. 96:1606-1612, 2004.
16. LAVIOLA, L., G. BELSANTI, A. M. DAVALLI, et al. Effects of streptozocin diabetes and diabetes treatment by islet transplantation on in vivo insulin signaling in rat heart. Diabetes 50:2709-2720, 2001.
17. LASER, M., V. S. KASI, M. HAMAWAKI, G. I. V. COOPER, C. KERR, and D. KUPPUSWAMY. Differential activation of p70 and p85 S6 kinase isoforms during cardiac hypertrophy in the adult mammal. J. Biol. Chem. 273:24610-24619, 1998.
18. MALHOTRA, A., T. F. SCHAIBLE, J. CAPASSO, and J. SCHEUER. Correlation of myosin isoenzyme alterations with myocardial function in physiologic and pathologic hypertrophy. Eur. Heart. J. 5:61-67, 1984.
19. MATSUI, T., L. Li, J. C. Wu, S. A. COOK, et al. Phenotypic spectrum caused by transgenic overexpression of activated AKT in the heart. J. Biol. Chem. 277:22896-22901, 2002.
20. MC MULLEN, J. R., T. SHIOI, L. ZHANG, et al. Phosphoinositide 3-kinase (p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy. Proc. Natl. Aca. Sci. USA 100:12355-12360, 2003.
21. MOORE, R. L., T. I. R. MUSCH, V. YELAMARTY, et al. Chronic exercise alters contractility and morphology of isolated cardiac myocytes. Am. J. Physiol. (Cell Physiol) 264:C1180-C1189, 1993.
22. MORISCO, C., D. ZEBROWSKI, G. CONDORELLI, P. TSICHLIS, S. F. VATNER, and J. SADOSHIMA. The AKT/glycogen synthase kinase 3β pathway regulates transcription of atrial natriuretic factor induced by β-adrenergic receptor stimulation in cardiac myocytes. J. Biol. Chem. 275:14466-14475, 2000.
23. NGUYEN, Q. T., F. COLOMBO, R. CLEMENT, H. GOSSELIN, J. L. ROULEAU, and A. CALDERONE. ATI receptor antagonist therapy preferentially ameliorated right ventricular function and phenotype during the early phase of remodelling post MI. Br. J. Pharmacol. 138:1485-1494, 2003.
24. NICOL, R. L., N. FREY, G. PEARSON, M. COBB, J. RICHARDSON, and E. N. OLSON. Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 20: 2757-2767, 2001.
25. ONO, K., A. MATSUMORI, T. SHIOI, Y. FURUKAWA, and S. SASAYAMA. Cytokine gene expression after myocardial infarction in rat hearts. Circulation 98:149-156, 1998.
26. PEARSON, R. B., P. B. DENNIS, J. W. HAN, et al. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14:5279-5287, 1995.
27. PFEFFER, J. M., T. A. FISCHER, and M. A. PFEFFER, Angiotensin-converting enzyme inhibition and ventricular remodeling after myocardial infarction. Ann. Rev. Physiol. 37:805-828, 1995.
28. PULLEN, N., and G. THOMAS. The modular phosphorylation and activation of p70s6K. FEBS Lett. 410:78-82, 1997.
29. SCHUBERT, K. M., M. P. SCHEID, and V. DURONIO. Ceramide inhibits protein kinase B/Akt by promoting dephosphorylation of serine 473. J. Biol. Chem. 275:13330-13335, 2000.
30. SHIOI, T., P. M. KANG, P. S. DOUGLAS, et al. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 19:2537-2548, 2000.
31. SHIOI, T., J. R. MCMULLEN, O. TARNAVSKI, et al. Rapamycin attenuates load-induced cardiac hypertrophy in mice. Circulation 107:1664-1670, 2003.
32. STOKOE, D., L. R. STEPHENS, T. COPELAND, et al. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science 277:567-570, 1992.
33. TANAKA, Y., M. V. GAVRIELIDES, Y. MITSUUCHI, T. FUJII, and M. G. KAZANIETZ. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J. Biol. Chem. 278: 33753-33762, 2003.
34. WELSH, G. I., C. WILSON, and C. G. PROUD. GSK: a Shaggy frog story. Trends Cell. Biol. 6:274-279, 1996.